— Events — 
Temenos
707-992-5015
www.temenos.center

Ketamine-Assisted Psychotherapy Group

 

11/30/20 — 2:00 p.m. - 5:00 p.m.

1 Bodega Ave.  “Studio One”

Petaluma CA 94952

 

Followup Integration Group by Zoom — Tuesday evening 12/1/20 — time to be arranged

 

Fee for KAP group & integration group: $525

 

Facilitated by Jessica McIninch, PsyD and Carl Spitzer, MD

 

Temenos is offering a ketamine-assisted psychotherapy group. Group therapy with ketamine is a profound way to further the benefits of ketamine therapy as it blends the deep internal dive into resilience that KAP clients are familiar with, with an opportunity to connect with like-minded others. This can help open new areas of awareness and deepen trust, as well as offer an opportunity to meet people who are on a similar path. Participants must be experienced with KAP. 

 

Being part of a ketamine group can be a vulnerable experience. Our staff appreciates this vulnerability and does everything possible to create a safe place, on both physical and psychological levels. Safety protocols include: COVID-related, physical space considerations, confidentiality guidelines, management of psychological space so that no one need share anything that feels too vulnerable, and a follow-up group to help integrate the experience.

 

Of course there is no ultimate safety, except perhaps through a sense of being profoundly interconnected. As we feel increasingly stable in ourselves, we can accept the truth of our vulnerability and decide to live fully anyway. It is a commitment to this kind of living that allows us to step into a group such as this. And stepping in leads in turn to an increase in interconnectedness and thus increases our sense of safety in the world.  

 

COVID protocols: 

  • Maximum of 4 participants

  • All participants and staff will wear masks 

  • Studio One is a large room with good ventilation 

  • A HEPA-quality air purifier will be utilized

  • Anyone symptomatic or having been exposed to COVID within the prior week cannot attend 

  • A medical check will be administered upon entering 

  • Follow-up Integration Session will be via Zoom 

For more information please fill out our contact form or email.

 

Weekly KAP Integration Group

 

Temenos provides a weekly integration group for clients who have previously participated in ketamine-assisted psychotherapy. This group provides clients the opportunity to benefit from ongoing, depth-oriented integration work in a safe, consistent setting with peers interested in deepening the insights achieved in medicine sessions.

For more information contact Jessica.

 

Ketamine Training for Clinicians

 

Four-part didactic training (via Zoom): 

Mondays from 7:00 p.m. to 8:30 p.m. — 1/11/21, 1/18/21, 1/25/21 & 2/1/21.

Fee: $500 (Plus $17.50 administration if paid by credit card)

Presenters: Carl Spitzer, MD; Christina Ingenito, LCSW; Jessica McIninch, PsyD; Jim Matto-Shepard, PhD (presenter bios)

 

Temenos is offering a four-part online training in ketamine-assisted psychotherapy (KAP) for clinicians and interns.  The modules will be live on four successive Monday nights and will be recorded for participants who cannot attend at the time of the presentation.

 

Experiential Training will be available upon completion of this didactic training or the equivalent (as determined by the Temenos Training Coordinator).

 

Temenos ketamine-assisted psychotherapy (KAP) training is designed to train psychotherapists to become competent beginning-level providers for KAP.  It will also serve as a foundational course for medical professionals who want to be part of a treatment team for KAP.  The training is set within the context of psychedelic-assisted psychotherapy (PAP) as a healing modality for our culture. Participants will learn not only about ketamine as a stand alone medicine and one that facilitates psychotherapy, but will also increase awareness and skills for psychedelic-assisted psychotherapy in general.  To optimize retention of complex information, the didactic portion of the course will be taught in four 90-minute sections over four weeks. 

 

This training discusses ketamine when used as an adjunct to psychotherapy for therapeutic reasons.  These include three basic categories: for a psychiatric indication such as treatment resistant depression or suicidality, for the facilitation of psychological work (psycholytic), and for psycho-spiritual exploration. 

 

The Historical, Cultural & Medical Context of KAP

 

  • The importance of context or story

  • Set and Setting

  • The cultural and historical context of psychedelics

  • Clinical work with non-ordinary states

  • The cultural and historical context of ketamine

  • Ketamine as the poor step-child of psychedelics

  • Legality and prescribing off-label

 

    

The many Flavors of K

 

  • Subjective experiences with ketamine 

  • Ketamine — “medicine,” a tool to facilitate psychotherapy, or a psychedelic?  Are these all aspects of the same thing?

  • Different approaches to KAP, infusion w/o much psychotherapy to psycholytic with an emphasis on psychotherapy

  • the experiential differences between troches, rapid dissolving tablets, nasal sprays, IM and IV ketamine. (what about suppositories?) 

  • Differential diagnosis — who is KAP appropriate for?

  • Ketamine as a medicine for treatment-resistant depression and suicidality

  • Is it appropriate to do psychedelic work with “well” people in clinic?

  • Dosages based on the goals of treatment

  • The therapeutic team — roles and responsibilities

 

 

Relevant Psychophysiology of KAP and Clinic Setup 

 

  • Chemistry and pharmacological mechanisms and how they relate to the phenomenology of ketamine.

  • Dosages, route of administration and bioavailability

  • Physical dangers & medical contraindications 

  • Managing psychiatric emergencies

  • What are potential side-effects and how are they treated

  • How to determine appropriate route and dose

  • Variables in how to order and store injectable & sublingual ketamine

  • Paperwork

  • Legal issues and the MD/psychotherapist alliance

  • Setting up an office

  • Group/ At home lozenges/ COVID/ Couples and more 

 

 

The process of KAP

 

  • Intake variables — diagnosis and client selection

  • Clarifying intention with the client

  • Creating the psycho-spiritual space for the session

  • Monadic versus dyadic treatment

  • Administration of ketamine, how and by whom

  • How to be in the unfolding session — different roles

  • Transference, boundaries and therapeutic “cleanliness”

  • Integration — where the rubber meets the road

  • When to refer out​

For more information about this training contact us here or call us at 707-992-5015.

 

Experiential Ketamine Training

for Clinicians

A legal, safe and easy approach to learning about  ketamine-assisted psychotherapy — set within the context of psychedelic-assisted psychotherapy.  

 

The focus of these classes is on the understanding and practice of a clinical model for treatment.

 

Ketamine, used as an adjunct to psychotherapy, can provide an experience of being able to handle the difficulties of life. It assists clients to uncover and speak about aspects of their history that have been too difficult to face, and increases their ability to be in relationship with defensive structures without denying or acting them out.

 

This experiential group training will provide clinicians an understanding of the subjective and therapeutic effects of ketamine-assisted psychotherapy from the inside out.

 

Learning Objectives:

  • Integrate knowledge about providing KAP in a clinic setting 

  • Develop skill in the practice of ketamine-assisted psychotherapy

  • An experience of the therapeutic benefits of ketamine 

    • As a psycholytic tool 

    • To build mindfulness & awareness of the body 

    • To strengthen a sense of inner resourcefulness

 

Details:

Fee:  $1000

Scheduling details will be up for Early 2021 soon.

 

Temenos Trainers:  Carl Spitzer, MD; Christina Ingenito, LCSW; Jessica McIninch, PsyD & Jim Matto-Shepard, PhD

 

~ Links ~

Links to Websites of Colleagues

Multidisciplinary Association for Psychedelic Studies

 

Sage Integrative Health

 

Polaris Insight Center

 

Center for Transformational Psychotherapy

 

Kriya Institute

 

Psychedelic Support

Reference Material on Ketamine

https://www.wired.com/story/ketamine-stirs-up-hope-controversy-as-a-depression-drug/

https://neurohacker.com/exploring-the-use-of-ketamine-in-integrative-medicine-with-dr-jeffrey-becker

https://psychedelic.support/resources/ketamine-breakout-psychedelic-therapy/

https://www.tandfonline.com/doi/full/10.1080/02791072.2019.1587556

https://www.vice.com/en_us/article/pajkjy/opinion-the-new-ketamine-based-antidepressant-is-a-rip-off

https://www.mdmag.com/medical-news/ketamine-infusion-abstinence-cocaine-dependent-patients?fbclid=IwAR1iRDgx-6-uckX_o-ggcdq_w-CNAhox5ljnefZGCZJBWp2h7L0DV4rjIKk

https://maps.org/news/bulletin/articles/436-maps-bulletin-spring-2019-vol-29,-no-1/7718-paradigms-of-ketamine-treatment-spring-2019

 

https://psychedelicstoday.com/2019/05/07/veronika-gold-methods-of-ketamine-assisted-psychotherapy/?fbclid=IwAR1erGZsj7_Fhq-Yi1l5Whkxpz6DcirVvzVUppu9J2vFVVM8NZvMM450fvQ

 

https://psychedelic.support/resources/ketamine-breakout-psychedelic-therapy/?fbclid=IwAR1tlAfREk3bs3Qux5b5fa6yeoLRV648mw21gegOfiGvmgQnNsvzHgHpeVE

 

https://www.mdmag.com/medical-news/ketamine-infusion-abstinence-cocaine-dependent-patients?fbclid=IwAR1iRDgx-6-uckX_o-ggcdq_w-CNAhox5ljnefZGCZJBWp2h7L0DV4rjIKk

 

 

Reference Material on MDMA

 

http://www.maps.org/news/media/7171-cnn-active-ingredient-in-ecstasy-may-help-veterans-with-ptsd,-study-finds?pk_campaign=May2018-Media&pk_kwd=cnn-intro

 

http://www.maps.org/news/media/7186-reuters-ecstasy-therapy-may-help-service-veterans-suffering-ptsd?pk_campaign=May2018-Media&pk_kwd=reuters-intro

Michael Corbin interviews Michael Pollan

 

http://www.maps.org/news/media/7158-press-release-mdma-assisted-psychotherapy-shows-promise-for-veterans-with-chronic,-treatment-resistant-ptsd

 

https://radio.foxnews.com/2018/05/02/yet-another-podcast-on-drugs/?1